Evidence map›Paper›PMID 31344954›Full record

ArticleNanomaterials (Basel, Switzerland)2019

Glucose Sensor Using Redox Active Oligonucleotide-Templated Silver Nanoclusters.

Kathryn L Schroeder, Renee V Goreham, Thomas Nann

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kathryn L SchroederThe MacDiarmid Institute, Victoria University of Wellington, Wellington 6012, New Zealand.ORCID 0000-0001-5314-2043
Renee V GorehamThe MacDiarmid Institute, Victoria University of Wellington, Wellington 6012, New Zealand. renee.goreham@newcastle.edu.au.ORCID 0000-0002-6511-6464
Thomas NannThe MacDiarmid Institute, Victoria University of Wellington, Wellington 6012, New Zealand. thomas.nann@newcastle.edu.au.ORCID 0000-0002-2723-6553

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Redox active, photoluminescent silver nanoclusters templated with oligonucleotides were developed for glucose sensing. The silver nanoclusters had a photoluminescent emission at 610 nm that reversibly changed to 530 nm upon oxidation. The reversible emission change was measured with photoluminescent spectroscopy and used to detect H

Indexed as

biosensingDNAglucosenanoclusteroxidationphotoluminescencereversiblesilver

Identifiers

PMID31344954
PMCPMC6722757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.